Author: administrator

Immunomodulatory effects and improved outcomes with cisplatin-versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer

Galsky, M. D., Guan, X., Rishipathak, D., Rapaport, A. S., Shehata, H. M., Banchereau, R., Yuen, K., Varfolomeev, E., Hu, R., Han, C., Li, H., Liang, Y., Vucic, D., Wang, L., Zhu, J., Yu, H., Herbst, R. H., Hajaj, E., Kiner, E., . . . Mariathasan, S. (2024). Cell Reports Medicine, 5(2), 101393. https://doi.org/10.1016/j.xcrm.2024.101393 In metastatic urothelial […]

Automated Characterization Method for Validation of Epigenomic Editors in T Cells

Now Watchinghttps://youtu.be/-oRv-U2VMHg To view the transcript click here. Robust characterization methods are important analytical tools for phenotypic characterization in cell and gene therapy. For high-parameter flow cytometry methods, sample preparation is a highly complex and mostly manual procedure. Traditional flow cytometry methods are limited in throughput and resource intensive, which make them suboptimal for discovery screening […]

Product Marketing Manager

Product Marketing Manager Curiox Biosystems is a pioneering life science technology company dedicated to automating and standardizing sample preparation for cell analysis with its innovative Curiox C-FREE™ technology. Traditional sample preparation methods often involve labor-intensive manual operations, particularly the centrifugation step, leading to variability and requiring highly skilled personnel. Curiox addresses these challenges by automating […]

Conference: Curiox is Attending SLAS Boston 2024

We’re excited to announce we’ll be exhibiting at #SLAS2024 in Boston! This year we’ll be showcasing our Laminar Wash Technology that will help you and your team support Innovation at Every Turn. We’re looking forward to seeing you at the Boston Convention and Exhibition Center. Learn more: www.slas.org/2024.  Make sure to carve out time to stop by our […]

Join Us at 7th German Mass Cytometry User Forum

Curiox Biosystems is excited to announce our participation in the 7th German Mass Cytometry User Forum, taking place on January 25-26, 2024, in Dresden, Germany. This forum is a premier event for professionals and researchers in the field of mass cytometry, offering a unique opportunity to explore the latest advancements, share insights, and connect with industry […]

Conference: Cell Therapy Analytical Development Summit

Curiox is excited to be attending Cell Therapy Analytical Development Summit in Boston, MA! Come visit our on-site team to learn more about Laminar Wash! We will also be having a Poster Presentation, “Title: Non-Centrifuge Processing of Whole Blood” given by our FAS Manager, Nadiezda Fernandez Oropeza on Dec. 5th at 3:30PM. Subscribe to our […]

Conference: MetroFlow 2023

Curiox is excited to be attending MetroFlow in New York, NY! Come visit our on-site team to learn more about Laminar Wash! Subscribe to our newsletter Get updates about upcoming webinar technical application information and product announcements when you subscribe to the Curiox newsletter.

Curiox Biosystems to Advance Next-Generation Cancer Cell Therapies Through Collaboration with Leading Cancer Researcher

BOSTON, Sep. 13, 2023 /PRNewswire/ — Curiox Biosystems, a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, is pleased to announce its collaboration with Dr. Marco Ruella, an Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn), to support efforts in the […]

Curiox Biosystems Inc., Announces Initial Public Offering (IPO)

Curiox Biosystems Inc., Announces Initial Public Offering (IPO) August 14th, 2023 SEOUL, SOUTH KOREA, Aug. 14, 2023 /PRNewswire/ — Curiox Biosystems Inc., a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, announced today the pricing of its initial public offering of 1,400,000 shares of its common stock at a […]